Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Cyclically Adjusted PB Ratio : 5.81 (As of Jun. 20, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-20), Biofil Chemicals & Pharmaceuticals's current share price is ₹60.99. Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₹10.49. Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 5.81.

The historical rank and industry rank for Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

NSE:BIOFILCHEM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.25 Med: 6.5 Max: 44.23
Current: 5.88

During the past years, Biofil Chemicals & Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 44.23. The lowest was 4.25. And the median was 6.50.

NSE:BIOFILCHEM's Cyclically Adjusted PB Ratio is ranked worse than
85.66% of 753 companies
in the Drug Manufacturers industry
Industry Median: 1.85 vs NSE:BIOFILCHEM: 5.88

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biofil Chemicals & Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was ₹11.185. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹10.49 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation

Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Biofil Chemicals & Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cyclically Adjusted PB Ratio

Get a 7-Day Free Trial

8.18

6.47

4.26

5.77

Biofil Chemicals & Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cyclically Adjusted PB Ratio	Get a 7-Day Free Trial															4.26	-	4.76	-	5.77

Competitive Comparison of Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.

Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio	=	Share Price	/	Cyclically Adjusted Book per Share
	=	60.99	/	10.49
	=	5.81

Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Biofil Chemicals & Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book	=	Book Value per Share	/	CPI of Mar. 2024 (Change)	*	Current CPI (Mar. 2024)
	=	11.185	/	153.0345	*	153.0345
	=	11.185

Current CPI (Mar. 2024) = 153.0345.

Biofil Chemicals & Pharmaceuticals Quarterly Data

	Book Value per Share	CPI	Adj_Book
201406	4.863	94.103	7.908
201409	4.955	96.780	7.835
201412	0.000	96.780	0.000
201503	5.171	97.163	8.144
201506	0.000	99.841	0.000
201509	5.258	101.753	7.908
201512	0.000	102.901	0.000
201603	6.702	102.518	10.004
201606	0.000	105.961	0.000
201609	6.886	105.961	9.945
201612	0.000	105.196	0.000
201703	7.802	105.196	11.350
201706	0.000	107.109	0.000
201709	7.906	109.021	11.098
201712	0.000	109.404	0.000
201803	8.091	109.786	11.278
201806	0.000	111.317	0.000
201809	8.010	115.142	10.646
201812	0.000	115.142	0.000
201903	8.388	118.202	10.860
201906	0.000	120.880	0.000
201909	8.898	123.175	11.055
201912	0.000	126.235	0.000
202003	9.145	124.705	11.222
202006	0.000	127.000	0.000
202009	9.848	130.118	11.582
202012	0.000	130.889	0.000
202103	9.911	131.771	11.510
202106	0.000	134.084	0.000
202109	10.149	135.847	11.433
202112	0.000	138.161	0.000
202203	10.347	138.822	11.406
202206	0.000	142.347	0.000
202209	10.501	144.661	11.109
202212	0.000	145.763	0.000
202303	10.632	146.865	11.079
202306	0.000	150.280	0.000
202309	10.858	151.492	10.969
202312	0.000	152.924	0.000
202403	11.185	153.035	11.185

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.

Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (NSE:BIOFILCHEM) » Definitions » Cyclically Adjusted PB Ratio

Traded in Other Exchanges

524396:India

Address

11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015

Website

https://www.biofilgroup.net

Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Headlines

No Headlines